|
Real-time Estimate
Cboe BZX
11:08:23 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 43.32 USD | +0.78% |
|
-12.18% | -34.70% |
| 07:05am | Arrowhead Pharmaceuticals, Inc. Presents at Jefferies Global Healthcare Conference 2026, Nov-18-2026 11:00 AM | |
| 11-12 | Arrowhead Pharmaceuticals, Inc., 2026 Earnings Call, Nov 12, 2026 |
| Market Cap | 6.08B 5.52B 5.1B 4.6B 8.68B 568B 9.01B 61.41B 24.29B 306B 22.8B 22.32B 968B | P/E 2027 * |
-8.33x | P/E 2028 * | -13.4x |
|---|---|---|---|---|---|
| Enterprise Value | 5.72B 5.19B 4.8B 4.33B 8.17B 535B 8.48B 57.81B 22.87B 288B 21.47B 21.01B 911B | EV / Sales 2027 * |
18.2x | EV / Sales 2028 * | 10.5x |
| Free-Float |
94.57% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ARWR | Delayed | |
| ARWR | Real-time | ||
| HDP1 | End-of-day quote | ||
| HDP1 | Real-time | ||
| 0HI3 | Delayed | ||
| HDP1 | Real-time | ||
| HDP1 | Delayed | ||
| HDP1 | Delayed | ||
| HDP1 | Delayed |
Last Transcript: Arrowhead Pharmaceuticals, Inc.
| 1 day | +0.78% | ||
| 1 week | -12.18% | ||
| Current month | -27.63% | ||
| 1 month | -24.25% | ||
| 3 months | -50.68% | ||
| 6 months | -41.38% | ||
| Current year | -34.70% |
| 1 week | 42.07 | 48.99 | |
| 1 month | 42.07 | 62 | |
| Current year | 42.07 | 95.49 | |
| 1 year | 37.06 | 95.49 | |
| 3 years | 9.57 | 95.49 | |
| 5 years | 9.57 | 95.49 | |
| 10 years | 1.2 | 95.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2007-11-30 | |
Daniel Apel
DFI | Director of Finance/CFO | - | 2025-05-12 |
Tao Pei
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | - | |
Mauro Ferrari
BRD | Director/Board Member | 66 | 2010-08-18 |
Michael Perry
BRD | Director/Board Member | 66 | 2011-12-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/18/26 | Sell | Director | -2,000 | 0.0014% | ||
| 8/18/26 | Sell | Director | -11,600 | 0.0082% | ||
| 6/15/26 | Free | Director | 11,882 | 0.0084% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.78% | -12.18% | +7.12% | +50.00% | 6.08B | ||
| -1.34% | -4.12% | +53.70% | +68.83% | 66.37B | ||
| +1.08% | -1.26% | +9.61% | +91.79% | 58.86B | ||
| +0.68% | +0.54% | +26.08% | +86.79% | 55.22B | ||
| -2.33% | -4.07% | +10.71% | +114.45% | 47.21B | ||
| -0.71% | -6.95% | +17.56% | +24.43% | 42.45B | ||
| -2.58% | +2.22% | +14.73% | +41.28% | 36.44B | ||
| -1.85% | -11.72% | +126.01% | +634.08% | 35.19B | ||
| -0.17% | -1.94% | +82.25% | +57.30% | 32.66B | ||
| -1.43% | -1.37% | -40.93% | +383.73% | 26.73B | ||
| Average | -0.77% | -3.70% | +30.68% | +155.27% | 41B | |
| Weighted average by Cap. | -0.78% | -3.03% | +32.97% | +141.09% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 315M 286M 264M 238M 449M 29.39B 466M 3.18B 1.26B 15.86B 1.18B 1.16B 50.11B | 542M 492M 454M 410M 774M 50.61B 803M 5.47B 2.16B 27.31B 2.03B 1.99B 86.28B |
| Net income | -742M -674M -622M -562M -1.06B -69.35B -1.1B -7.5B -2.97B -37.42B -2.78B -2.73B -118B | -485M -440M -406M -367M -692M -45.28B -719M -4.9B -1.94B -24.43B -1.82B -1.78B -77.2B |
| Net Debt | -356M -323M -299M -269M -508M -33.26B -528M -3.6B -1.42B -17.95B -1.34B -1.31B -56.7B | -392M -356M -329M -297M -560M -36.64B -581M -3.96B -1.57B -19.77B -1.47B -1.44B -62.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | US$43.41 | +0.98% | 427,196 |
| 26-11-17 | US$42.99 | -2.76% | 3,703,616 |
| 26-11-16 | US$44.21 | -7.47% | 1,863,749 |
| 26-11-13 | US$47.78 | +1.34% | 3,113,499 |
| 26-11-12 | US$47.15 | -4.48% | 2,164,345 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ARWR Stock
Select your edition
All financial news and data tailored to specific country editions
















